New York A 1559: Establishes a moratorium on the transport of natural gas from hydraulic fracturing; requires an environmental impact report thereon

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A01559 Summary:

BILL NOA01559 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORRosenthal (MS)

&nbsp

COSPNSR

&nbsp

MLTSPNSRCook

&nbsp

Add §3153-a, Pub Auth L; add §99-ss, St Fin L

&nbsp

Creates the lymphedema and lymphatic diseases research grants program; provides such grants, not to exceed $50,000, would be awarded on a competitive basis to biomedical research institutions conducting direct research related to lymphedema and lymphatic disease.

Go to top A01559 Actions:

BILL NOA01559 

&nbsp

01/10/2025referred to health

01/07/2026referred to health

Go to topA01559 Committee&nbspVotes:

Go to topA01559 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA01559 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 1559

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 10, 2025
 ___________

 Introduced by M. of A. ROSENTHAL -- Multi-Sponsored by -- M. of A. COOK
 -- read once and referred to the Committee on Health

 AN ACT to amend the public authorities law, in relation to establishing
 a lymphedema and lymphatic diseases research grants program; and to
 amend the state finance law, in relation to creating the lymphedema
 and lymphatic diseases research and education fund

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public authorities law is amended by adding a new
 2 section 3153-a to read as follows:
 3 § 3153-a. Lymphedema and lymphatic diseases research grants program.
 4 1. The foundation shall, within available appropriations, establish the
 5 lymphedema and lymphatic diseases research grants program, hereafter
 6 "grants program". The grants program shall be administered by the foun-
 7 dation, in consultation with the department of health. Such grants
 8 program funds shall be used to provide financial assistance in the form
 9 of grants, not to exceed fifty thousand dollars per grant, to New York
 10 state biomedical research institutions for working capital to further
 11 new and emerging research and development for the diagnosis and treat-
 12 ment of lymphedema and lymphatic diseases. Such grants shall be awarded
 13 on a competitive basis to biomedical research institutions responding to
 14 requests for proposals issued by the foundation when funds are appropri-
 15 ated.
 16 2. (a) "Biomedical research institution" shall mean a not-for-profit
 17 university, college, hospital, private or federal research laboratory
 18 located in New York state, or a consortium of such entities, that
 19 conducts an intensive and ongoing program of research and development
 20 directly related to lymphedema and/or lymphatic diseases research.
 21 (b) "Lymphedema" shall mean an accumulation of lymphatic fluid in the
 22 interstitial tissue that causes swelling, most often in the arms and/or
 23 legs, and occasionally in other parts of the body, from any cause.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD03938-01-5

 A. 1559 2

 1 (c) "Lymphatic diseases" shall include but not be limited to: insuf-
 2 ficiency of lymphatic circulatory function (to include all forms of
 3 lymphedema), lipedema, complex congenital diseases of the lymphatic
 4 vasculature, including lymphangiomatosis, lymphangioleio-myomatosis,
 5 lymphangiectasias, lymphangiomas, cystic hygromas, Gorham's disease,
 6 lymphangiosarcoma, and complex vascular/lymphatic malformations.
 7 3. In addition to such other criteria as the foundation may adopt in
 8 rules and regulations for the consideration of applications for grants
 9 pursuant to subdivision one of this section, the foundation shall:
 10 (a) determine that the applicant is unable to obtain sufficient fund-
 11 ing on reasonable terms from other public or private sources to permit
 12 the institution's planned investment to proceed without the required
 13 assistance;
 14 (b) give priority to those applications for assistance from biomedical
 15 research institutions that secure private support for research or commit
 16 new resources to the expansion of lymphedema and lymphatic diseases
 17 research; and
 18 (c) consider the potential long term economic benefits to the state of
 19 awarding the specif